Potassium Replacement Calculator
Calculate potassium replacement dosing from deficit and target serum potassium level. Enter values for instant results with step-by-step formulas.
Formula
Estimated Deficit (mEq) = based on severity tiers: mild (100 mEq per 1 mEq/L below 4.0), moderate (200 mEq per 1 mEq/L below 3.5), severe (400+ mEq per 1 mEq/L below 3.0)
Potassium deficit estimation is inherently approximate because 98% of total body potassium is intracellular. A 0.3 mEq/L decrease in serum K below 3.5 corresponds to roughly 100 mEq total body deficit. The relationship is nonlinear with progressively larger deficits at lower serum levels. Actual replacement needs vary based on ongoing losses, acid-base status, and renal function.
Worked Examples
Example 1: Moderate Hypokalemia in Post-Surgical Patient
Problem: A 70 kg patient 2 days post-abdominal surgery has a serum K of 3.0 mEq/L with target of 4.0 mEq/L. Normal renal function. Patient is tolerating oral intake.
Solution: Current K: 3.0 mEq/L, Target: 4.0 mEq/L\nSeverity: Moderate hypokalemia\nEstimated deficit: ~200-400 mEq\nRecommended: IV 20 mEq KCl at 10 mEq/hr + Oral 40 mEq KCl\nRecheck level in 2-4 hours after IV dose\nExpected rise: ~0.3 mEq/L per 40 mEq replaced
Result: IV Dose: 20 mEq | Oral Dose: 40 mEq | Recheck in 2-4 hours | Estimated Deficit: ~300 mEq
Example 2: Severe Hypokalemia with EKG Changes
Problem: A 65 kg patient presents with K of 2.2 mEq/L, EKG showing U waves and prolonged QT. Target K 4.0 mEq/L. Normal renal function.
Solution: Current K: 2.2 mEq/L, Target: 4.0 mEq/L\nSeverity: SEVERE hypokalemia - medical emergency\nEstimated deficit: ~500-800 mEq\nRecommended: IV 40 mEq KCl via central line at 20 mEq/hr\nContinuous cardiac telemetry MANDATORY\nCheck magnesium level and replace if low\nRecheck K every 1-2 hours during active replacement
Result: IV Dose: 40 mEq via central line | Rate: 20 mEq/hr | Continuous monitoring | Check Mg level
Frequently Asked Questions
How is potassium deficit estimated from serum levels?
Estimating total body potassium deficit from serum levels is inherently imprecise because only about 2 percent of total body potassium is extracellular and measurable in serum, while 98 percent resides intracellularly. As a general approximation, each 0.3 mEq/L decrease in serum potassium below 3.5 mEq/L corresponds to approximately a 100 mEq total body deficit. However, this relationship is not linear; as potassium drops further, the deficit per unit decrease grows larger because intracellular stores become progressively depleted. A patient with a serum K of 3.0 mEq/L may have a deficit of 200 to 400 mEq, while a patient with K of 2.0 mEq/L may have a deficit of 400 to 800 mEq. Factors like acid-base status also affect the relationship between serum and total body potassium, with alkalosis shifting potassium intracellularly and making serum levels appear lower.
What is the maximum safe IV potassium infusion rate?
The maximum safe IV potassium infusion rate depends on the access site and clinical urgency. For peripheral IV access, the generally accepted maximum rate is 10 mEq per hour at a concentration no greater than 40 mEq per liter, as higher concentrations cause painful phlebitis and vein irritation. For central venous access, rates up to 20 mEq per hour can be administered at concentrations up to 80 mEq per liter, though some critical care protocols allow up to 40 mEq per hour in life-threatening situations with continuous cardiac monitoring and frequent serum level checks every one to two hours. Regardless of the route, continuous telemetry monitoring is mandatory when infusing potassium at rates greater than 10 mEq per hour. An important safety principle is that potassium should never be given as an IV push or rapid bolus because this can cause fatal cardiac arrest.
When should oral versus IV potassium replacement be used?
Oral potassium replacement is preferred whenever possible because it is safer, more physiological, less painful, and less likely to cause dangerous hyperkalemia from overshoot. Oral replacement is appropriate for mild hypokalemia of 3.0 to 3.5 mEq/L in patients who can tolerate oral intake, chronic potassium supplementation, and outpatient management. Common oral formulations include potassium chloride tablets (8 to 20 mEq each), liquid solutions, and effervescent preparations. IV replacement is necessary when serum potassium is below 2.5 mEq/L, when the patient is symptomatic with arrhythmias or severe weakness, when the patient is NPO or has severe nausea and vomiting preventing oral intake, or when rapid correction is needed such as in digitalis toxicity. Many moderate cases benefit from a combination approach using IV replacement for initial rapid correction followed by oral supplementation for ongoing maintenance.
What monitoring is required during potassium replacement?
Monitoring during potassium replacement therapy depends on the severity of hypokalemia and the rate of replacement. For severe hypokalemia or IV replacement rates exceeding 10 mEq per hour, continuous cardiac telemetry monitoring is essential to detect arrhythmias including peaked T waves, prolonged QT interval, ST depression, and U waves that may indicate dangerous potassium levels. Serum potassium levels should be rechecked every 2 to 4 hours during active IV replacement and every 4 to 6 hours during oral replacement. Renal function (BUN, creatinine, urine output) must be monitored because impaired kidney function significantly increases the risk of hyperkalemia from replacement therapy. Magnesium levels should be checked concurrently because hypomagnesemia makes hypokalemia refractory to treatment. Patients should be monitored for symptoms of hypokalemia resolution (improved weakness, resolution of EKG changes) and hyperkalemia development (bradycardia, peaked T waves).
Why does hypomagnesemia need to be corrected before potassium replacement?
Hypomagnesemia is present in approximately 40 to 60 percent of patients with hypokalemia, and correcting magnesium deficiency is essential for successful potassium repletion. Magnesium is required for the proper function of the Na-K-ATPase pump, which maintains the intracellular potassium gradient and is the primary mechanism for potassium reabsorption in the renal tubules. When magnesium is deficient, the Na-K-ATPase pump functions poorly, leading to increased renal potassium wasting that persists regardless of how much potassium is administered. This creates a situation where potassium replacement appears ineffective, with levels remaining low despite aggressive supplementation. The recommended approach is to check and correct magnesium levels simultaneously with potassium replacement. Typically, 1 to 2 grams of IV magnesium sulfate or oral magnesium oxide should be administered alongside potassium repletion in patients with documented or suspected hypomagnesemia.
How does acid-base status affect potassium levels?
Acid-base disturbances have a significant and clinically important effect on serum potassium levels through transcellular shifts. In metabolic acidosis, hydrogen ions move into cells in exchange for potassium ions moving out, raising the serum potassium level by approximately 0.6 mEq/L for each 0.1 unit decrease in pH. This means a patient in diabetic ketoacidosis with a pH of 7.1 and a serum K of 5.0 may actually have severe total body potassium depletion that will become apparent as the acidosis is corrected. Conversely, metabolic alkalosis causes potassium to shift intracellularly, lowering serum levels by approximately 0.3 to 0.5 mEq/L for each 0.1 unit increase in pH. This is why vomiting-induced metabolic alkalosis commonly causes hypokalemia. Understanding these relationships is critical for planning potassium replacement because the true deficit may be much larger or smaller than what the serum level initially suggests.